Edition:
United Kingdom

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

24.06USD
23 Aug 2019
Change (% chg)

$-1.23 (-4.86%)
Prev Close
$25.29
Open
$25.16
Day's High
$25.64
Day's Low
$23.94
Volume
220,591
Avg. Vol
230,736
52-wk High
$33.79
52-wk Low
$17.90

About

Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly... (more)

Overall

Beta: --
Market Cap(Mil.): $1,043.82
Shares Outstanding(Mil.): 41.74
Dividend: --
Yield (%): --

Financials

  EDIT.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -3.19 -- --
ROI: -42.42 8.95 14.48
ROE: -63.35 10.09 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates